<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02131389</url>
  </required_header>
  <id_info>
    <org_study_id>PS-1001</org_study_id>
    <nct_id>NCT02131389</nct_id>
  </id_info>
  <brief_title>Multi-Site, Post-Market Study of the ICONACY I-Hip System</brief_title>
  <official_title>Non-Randomized, Multi-Site, Post-Market Study of the ICONACY I-Hip System (Protocol No. PS-1001)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iconacy Orthopedic Implants, LLC.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iconacy Orthopedic Implants, LLC.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use and efficacy of the I-Hip for primary total
      hip replacement surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic Success as a Measure of Radiolucency and Component Migration</measure>
    <time_frame>2 years</time_frame>
    <description>A subject will be considered a failure for Overall Radiographic Success if one or more of the below conditions are met:
The subject will be considered a RADIOGRAPHIC FAILURE if:
there is a complete radiolucent line&gt; 3mm wide at the bone/cement interface or
there is a &gt;5 degree migration (shift) of the component or
there is a &gt;5 mm migration (shift) of the component.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of Harris Hip Score (with Charnley Score and other comorbidities considered)</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction clinical assessment utilizing questionnaire</measure>
    <time_frame>2 years</time_frame>
    <description>Clinical assessment of patient satisfaction will be made by utilizing a Patient Satisfaction (PS) questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Revision of Implant Prosthesis as a Measure of Efficacy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Degenerative Joint Disease</condition>
  <arm_group>
    <arm_group_label>Iconacy Hip System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Iconacy hip system prosthesis components</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iconacy Hip System</intervention_name>
    <arm_group_label>Iconacy Hip System</arm_group_label>
    <other_name>Iconacy I-Hip</other_name>
    <other_name>I-Hip</other_name>
    <other_name>iHip</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A candidate for primary hip replacement on this operative hip.

          -  Is 30 to 80 years of age.

          -  Has hip joint disease related to one or more of the following:

               -  Degenerative joint disease, (including osteoarthritis or post-traumatic
                  arthritis)

               -  Avascular Necrosis (AVN).

          -  Will be available for evaluation for the duration of the study.

          -  Is able and willing to speak and read English, read and sign the informed consent,
             fill out the WOMAC and Patient Satisfaction questionnaires, and follow all study
             procedures.

        Exclusion Criteria:

          -  Is younger than 30 years of age or older than 80 years of age.

          -  Has undergone partial hip replacement or previous ORIF (open reduction internal
             fixation of femur or acetabulum).

          -  Has undergone total hip replacement on this hip in the past (no revisions allowed in
             study).

          -  Infection, or history of infection, acute or chronic, in the hip joint, or acute or
             chronic unresolved systemic infection.

          -  Is currently experiencing radicular pain from the spine down operative leg.

          -  Has participated in an IDE/IND clinical investigation with an investigational product
             in the last three months, or is involved in any personal injury litigation,
             medical-legal or worker's compensation claim.

          -  Is a known drug or alcohol abuser or has a psychological disorder that could affect
             the ability to complete patient reported questionnaires.

          -  Has been diagnosed with fibromyalgia or has a significant neurological or
             musculoskeletal disorder or disease that may adversely affect gait or weight bearing
             (e.g. muscular dystrophy, multiple sclerosis, Charcot disease).

          -  Has been diagnosed with Paget's disease or Congenital hip deformity (dysplasia and/or
             dislocation).

          -  Is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile
             rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.)

          -  Is Obese: (Defined for this study as having a BMI&gt;45).

          -  Has insufficient bone quality.

          -  Has loss of ligamentous structures.

          -  Has materials sensitivity.

          -  Is currently a prisoner.

          -  Is pregnant or lactating.

          -  Has a contralateral amputation.

          -  Has a medical condition with less than 2 years of life expectancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald L Pomeroy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pomeroy &amp; Rhoads Orthopaedics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Donald L Pomeroy, MD</last_name>
    <phone>502-364-9883</phone>
    <email>arthroplastyfoundation@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Empson, RN</last_name>
    <phone>502-364-0902</phone>
    <phone_ext>113</phone_ext>
    <email>empsonja@aol.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baptist Health Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Empson, RN</last_name>
      <phone>502-364-0902</phone>
      <phone_ext>113</phone_ext>
      <email>empsonja@aol.com</email>
    </contact>
    <investigator>
      <last_name>Donald L Pomeroy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sts. Mary &amp; Elizabeth Hospital - KentuckyOne Health</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Empson, RN</last_name>
      <phone>502-364-0902</phone>
      <phone_ext>113</phone_ext>
      <email>empsonja@aol.com</email>
    </contact>
    <investigator>
      <last_name>Donald L Pomeroy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2014</study_first_submitted>
  <study_first_submitted_qc>May 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2014</study_first_posted>
  <last_update_submitted>May 2, 2014</last_update_submitted>
  <last_update_submitted_qc>May 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Arthroplasties</keyword>
  <keyword>Prosthesis</keyword>
  <keyword>Iconacy</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Arthritis</keyword>
  <keyword>THA</keyword>
  <keyword>THR</keyword>
  <keyword>DJD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

